Insmed To Present at December 2024 Investor Conferences

Rhea-AI Summary

Insmed (Nasdaq: INSM) has announced its participation in two major investor conferences in December 2024. The company will present at the Evercore ISI HealthCONx Conference in Coral Gables, Florida, on December 4 at 11:15 a.m. ET, and at the Nasdaq 51st Investor Conference in London on December 11 at 10:30 a.m. GT (5:30 a.m. ET). Both presentations will be available via webcast on the company's investor relations website and will remain accessible for 30 days after the events.

BRIDGEWATER, N.J., Dec. 2, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:

• Evercore ISI HealthCONx Conference in Coral Gables, Florida, on Wednesday, December 4, 2024, at 11:15 a.m. ET.
• Nasdaq 51^st Investor Conference held in association with Morgan Stanley in London on Wednesday, December 11, 2024, at 10:30 a.m. GT / 5:30 a.m. ET.

These events will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company's early-stage research programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
(646) 812-4030
bryan.dunn@insmed.com

Michael V. Morabito, Ph.D.
Director, Investor Relations
(917) 936-8430
michael.morabito@insmed.com

Gianna De Palma
Manager, Investor Relations
(973) 886-2236
gianna.depalma@insmed.com

Media:

Mandy Fahey
Vice President, Corporate Communications
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-december-2024-investor-conferences-302313424.html

SOURCE Insmed Incorporated

FAQ

When is Insmed (INSM) presenting at the Evercore ISI HealthCONx Conference 2024?

Insmed will present at the Evercore ISI HealthCONx Conference in Coral Gables, Florida, on Wednesday, December 4, 2024, at 11:15 a.m. ET.

Where can I watch Insmed's (INSM) December 2024 investor conference presentations?

The presentations can be accessed through webcasts on Insmed's investor relations website at www.insmed.com, where they will be archived for 30 days following the live events.

What time is Insmed's (INSM) presentation at the Nasdaq 51st Investor Conference?

Insmed will present at the Nasdaq 51st Investor Conference in London on Wednesday, December 11, 2024, at 10:30 a.m. GT (5:30 a.m. ET).